Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Chris Hagen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of the American Society of Nephrology : JASN|March 28, 2003
Renal mRNA levels as prognostic tools in kidney diseasesMichael Eikmans, Hans J Baelde, E Chris Hagen, et al.
American Journal of Clinical Pathology|September 25, 2003
Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseasesJudy Savige, Wayne Dimech, Marvin Fritzler, et al.
European Heart Journal|August 19, 2007
Steroid responsive aortitisAntonie J H H M van Oostrom, E Chris Hagen, John M H de Klerk, et al.
British Journal of Clinical Pharmacology|December 17, 2008
The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, cross-over study (EMSCAP study)Birgit C P Koch, J Elsbeth Nagtegaal, E Chris Hagen, et al.
British Journal of Clinical Pharmacology|February 26, 2013
Long-term effects of melatonin on quality of life and sleep in haemodialysis patients (Melody study): a randomized controlled trialMarije Russcher, Birgit C P Koch, J Elsbeth Nagtegaal, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of the American Society of Nephrology : JASN|March 28, 2003
Renal mRNA levels as prognostic tools in kidney diseasesMichael Eikmans, Hans J Baelde, E Chris Hagen, et al.
American Journal of Clinical Pathology|September 25, 2003
Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseasesJudy Savige, Wayne Dimech, Marvin Fritzler, et al.
European Heart Journal|August 19, 2007
Steroid responsive aortitisAntonie J H H M van Oostrom, E Chris Hagen, John M H de Klerk, et al.
British Journal of Clinical Pharmacology|December 17, 2008
The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, cross-over study (EMSCAP study)Birgit C P Koch, J Elsbeth Nagtegaal, E Chris Hagen, et al.
British Journal of Clinical Pharmacology|February 26, 2013
Long-term effects of melatonin on quality of life and sleep in haemodialysis patients (Melody study): a randomized controlled trialMarije Russcher, Birgit C P Koch, J Elsbeth Nagtegaal, et al.
Pageof 1